Aptamer therapeutics useful in the treatment of complement-related disorders
US8436164B2 · kind B2 · utility
4Cited by
77References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 18, 2012 |
| Grant date | May 7, 2013 |
| Priority date | — |
| Expiry date | Jun 18, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/3533
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.